Breaking News
August 21, 2018 - Clinical Trials Balance Out Urban, Rural Cancer Survival Rates
August 21, 2018 - New target found for treating thoracic aortic aneurysm
August 21, 2018 - Tumor cells’ ‘tells’ may allow some cancer patients to dodge unnecessary chemotherapy
August 21, 2018 - Dehydration changes shape and activity of the brain, reduces task performance
August 21, 2018 - Scientists discover peptides that can be used as new antibiotic candidates
August 21, 2018 - ‘Compulsivity circuit’ may drive alcohol-seeking behavior in heavy drinkers
August 21, 2018 - Type 2 diabetes on the rise among youngsters
August 21, 2018 - Genital warts may promote HIV sexual transmission
August 21, 2018 - Drop the C-word to reduce anxiety and overtreatment, say experts
August 21, 2018 - Kid-friendly MRI equipment has advantages for grown-ups, too
August 21, 2018 - Scleroderma Foundation names Tulane professor as ‘Doctor of the Year’
August 21, 2018 - Chagas disease causes chronic heart disease and has spread outside of Latin America
August 21, 2018 - FDA stirs debate by approving ‘natural’ app
August 21, 2018 - Clay may help fight disease-causing bacteria in wounds
August 21, 2018 - Emerging field of diabetology could address growing crisis in health care
August 21, 2018 - Experts examine stool protein biomarkers that indicate inflammatory bowel disease
August 21, 2018 - Orphazyme Announces Enrollment of First Patient in Phase III Clinical Trial of Arimoclomol for ALS
August 21, 2018 - Ovarian cancer cells hoard iron to fuel growth
August 21, 2018 - New Biodesign fellows will focus on vision care
August 21, 2018 - Prenatal DDT Exposure Associated with Greater Risk of Autism
August 21, 2018 - Cruciferous vegetables found to protect against colon cancer in mice
August 21, 2018 - New studies point to a promising future for bioengineered teeth
August 21, 2018 - ACR expresses concerns on step therapy in a recent meeting with HSS Secretary
August 21, 2018 - Gene therapy with telomerase does not increase cancer risk, study shows
August 21, 2018 - Ovarian cancer screening influenced by unconscious bias, study shows
August 21, 2018 - Scientists report novel gene therapy that halts vision loss in canine model of blinding disease
August 21, 2018 - RxBenefits introduces new tailored and flexible approach to managing hospital pharmacy benefits
August 21, 2018 - Motif Bio Announces FDA Acceptance of New Drug Application With Priority Review for Iclaprim for Treatment of Acute Bacterial Skin and Skin Structure Infections
August 21, 2018 - Google Glass helps kids with autism read facial expressions, study finds
August 21, 2018 - Thrombospondin-1 contributes to development of aortic aneurysm in mice and humans, study finds
August 21, 2018 - National Foundation for Cancer Research receives Safeway Foundation grant
August 21, 2018 - Protein aggregation in neurons linked to gene regulation in Huntington’s disease
August 21, 2018 - Aravive Biologics gains Fast Track Designation for AVB-S6-500 from U.S. FDA
August 21, 2018 - FDA Approves Opdivo (nivolumab) for Certain Patients with Previously Treated Small Cell Lung Cancer
August 21, 2018 - Success of blood test for autism affirmed
August 21, 2018 - Diabetic patients with disrupted sleep may need more time to heal their wounds
August 21, 2018 - AADE honors six educators for achievements in diabetes education
August 21, 2018 - Scientists find two molecules that may combat cancer and chronic infections
August 21, 2018 - Two Strategies for Preventing Diabetes in Minority Patients
August 21, 2018 - Living as a Gallbladder Cancer Survivor
August 21, 2018 - Can we predict the long-term outcome of boys with ADHD?
August 21, 2018 - GBCA creates model for developing scientist-advocate collaborations in cancer research
August 21, 2018 - Healthy diet could help promote healthy cellular aging in women
August 21, 2018 - Researchers develop gene expression predictor for immunotherapy response in melanoma
August 21, 2018 - Genome sequences of ape parasites provide insights on origin and early evolution of malaria
August 21, 2018 - MDI Biological Laboratory introduces Morris Scientific Discovery Fund for eligible research programs
August 21, 2018 - Pediatric brain tumor patients who undergo radiation less likely to recall recently experienced events
August 21, 2018 - Micro-flow model reveals complex interactions between the brain’s blood vessels and nerve cells
August 21, 2018 - Study investigates impact of osteoporosis on risk of developing dementia
August 21, 2018 - Federal method fails to detect most stores that sell cigarettes to minors
August 21, 2018 - Workers in open office seating have less stress than those in private offices and cubicles
August 21, 2018 - 1 in 4 in U.S. Has a Disability, CDC Reports
August 21, 2018 - Studies provide new insights into the role of sleep in chronic pain
August 21, 2018 - Study shows that rogue proteins may underlie some ALS and frontotemporal dementia cases
August 21, 2018 - Elevated LDL cholesterol levels linked to higher risk of CVD death in young, healthy people
August 21, 2018 - Measles cases on the rise in Europe
August 21, 2018 - CURE Media Group welcomes CancerCare to Strategic Alliance Partnership Program
August 21, 2018 - Blood management program associated with fewer transfusions in orthopedic patients
August 21, 2018 - Researchers create the world’s first artificial retina
August 21, 2018 - Yale researchers identify racial disparities in prescribing opioids for chronic pain
August 21, 2018 - BOOST-3 clinical trial aims to improve outcomes for severe TBI patients
August 21, 2018 - New study highlights Alzheimer’s herpes link, experts say
August 21, 2018 - Airline crew don’t have significantly elevated risk of thyroid cancer, new study finds
August 21, 2018 - States leverage federal funds to help insurers lower premiums
August 21, 2018 - New badge course explores research around skeletal muscle as an endocrine organ
August 21, 2018 - TG Therapeutics Announces Completion of Target Enrollment in the ULTIMATE Phase 3 Trials in Multiple Sclerosis
August 21, 2018 - Increased levels of human herpesvirus ID’d in Alzheimer’s
August 21, 2018 - To help patients quash pain, researcher develops practical guide for health care providers
August 20, 2018 - Medicine on the front line to be presented at Medical Innovation 2018
August 20, 2018 - Harbour Biomed and Kelun-Biotech collaborate to develop, commercialize anti-PD-L1 antibody
August 20, 2018 - The man who sold America on vitamin D — and profited in the process
August 20, 2018 - Finding the light in antimicrobials
August 20, 2018 - Unique pain program helps surgical patients wean off opioids safely and effectively
August 20, 2018 - Strawberries could mitigate colonic inflammation
August 20, 2018 - FDA Accepts New Drug Application (NDA) to Review Midazolam Nasal Spray, an Investigational Product for the Acute Treatment of Seizure Clusters
August 20, 2018 - Using Facebook to help young adults quit smoking
August 20, 2018 - ‘Liquid biopsy’ predicts lymphoma therapy success within days | News Center
August 20, 2018 - 5 Questions with Jordan Orange, Chair of Pediatrics
August 20, 2018 - New assay may help improve both sarcoma diagnosis and treatment
August 20, 2018 - New information on the brain regions related to metacognition, tactile sense
Metformin Found Safe in Pregnant Women With Diabetes

Metformin Found Safe in Pregnant Women With Diabetes

image_pdfDownload PDFimage_print

Action Points

  • Note that this observational study suggests that women who take metformin during pregnancy have no increased risk of adverse pregnancy outcomes, beyond those that arise through the presence of diabetes.
  • Be aware that the authors did not analyze a group of women with diabetes but not treated with metformin.

Pregnant women who took metformin for pregestational diabetes had a higher risk for adverse outcomes, but this risk was linked to the diabetes, not the drug, researchers reported.

Pregnant women on metformin for other indications, such as polycystic ovary syndrome (PCOS), had no significantly increased risk for poor outcomes, Alice Panchaud, PhD, of the University of Geneva in Switzerland, and colleagues wrote online in the British Journal of Clinical Pharmacology.

Compared with a matched reference group of pregnant women not taking metformin, metformin users with diabetes were nearly four times more likely to give birth to an infant with major birth defects (odds ratio 3.95; 95% CI 1.77 to 9.41). However, there was no significantly increased risk for pregnant women on metformin for other reasons (OR 0.83; 95% CI 0.18 to 2.81), the study found.

Similarly, women taking metformin for pre-gestational diabetes had more than twice the risk for spontaneous abortion or stillbirth (OR 2.51; 95% CI 1.44 to 4.36), but women taking metformin for other indications had no significant risk increase (OR 1.38; 95% CI 0.74 to 2.59).

The results were similar for other pregnancy outcomes the study examined, including the risk for pre-term birth and assisted delivery.

“Metformin controls glycemia in pregnant women with gestational diabetes, and it has been shown to prevent adverse maternal and neonatal outcomes associated with hyperglycemia,” Panchaud et al said. “However, evidence regarding its safety and effectiveness to achieve glycemic targets in the management of type 2 diabetes in pregnancy is limited. Moreover, since metformin, as do most other drugs, crosses the placental barrier, embryological and fetal risks need to be considered when exposure occurs early in pregnancy.”

The researchers explained that the aim of the observational cohort study was to better characterize the safety of metformin use early in pregnancy, and to evaluate the risk of birth defects and pregnancy losses after first trimester exposure to metformin. “We took advantage of the several potential indications to disentangle the effect of metformin from the known effects of diabetes on pregnancy outcomes,” the team said.

At the time of the study, Panchaud was a research fellow at the Harvard T.H. Chan School of Public Health in Boston. “Our findings provide the first reassuring evidence that metformin might offer a cheaper and simpler alternative to insulin for the management of pregestational diabetes in pregnancy when effective,” she said in a statement.

The multi-center, prospective study included 471 pregnant women who were taking metformin, enrolled from 1993 to 2015. The vast majority (97%) started metformin before pregnancy and took the drug during their first trimester. The median dose was 1,325 mg. A total of 63% of participants were taking metformin for pregestational diabetes; 12% were taking the drug for PCOS; and the remainder, for other indications such as obesity, ovary stimulation, insulin resistance, glucose intolerance, and hyperglycemia.

For a reference group, the study included 497 randomly selected pregnant women matched to the treatment group in terms of study center, maternal age, and week of gestational age at enrollment. These women had not used metformin, insulin, or any other hypoglycemic agent at any time during their pregnancy.

The team used multivariate logistic regression analysis to look for associations between metformin use and pregnancy outcomes, and importantly, distinguished between women who were taking metformin for pregestational diabetes and those taking it for other indications.

“Whether diabetes increases a woman’s risk of having a spontaneous abortion has been under debate for a long time,” the researchers wrote. “Overall, studies suggest that poor metabolic control may be at increased risk of spontaneous abortion. Similarly, in our study the risk of pregnancy losses was higher (21%) in the group exposed to metformin with a diagnostic of pregestational diabetes than in the metformin-exposed group without pregestational diabetes (17%).”

The main limitation of the study, the authors said, was the lack of a reference group of pregnant women being treated for pregestational diabetes with other drugs, especially insulin. In addition, “although this is the largest study published to date, the sample size is still too small and follow-up duration too short to reach a final assessment on the safety and risks associated with the use of metformin in pregnancy. Future studies comparing metformin-exposed pregnancies with women with the same indication and treated with alternative therapies — e.g., on insulin — are warranted.”

The study was funded by the Swiss National Science Foundation.

Panchaud and co-authors declared having no conflicts of interest.

  • Reviewed by
    F. Perry Wilson, MD, MSCE Assistant Professor, Section of Nephrology, Yale School of Medicine and Dorothy Caputo, MA, BSN, RN, Nurse Planner

1969-12-31T19:00:00-0500

last updated

Tagged with:

About author

Related Articles